Oak review
A flat, all-dose compounded price with an oral option and a genuinely thorough intake — undercut by a headline that isn't the real month-to-month number and terms that lock you in hard once the box ships.
- FSA / HSA-eligible
- Independently scored
- Verified
Referral link, walled off from the rating
Fact-checked against the record by Reed Ellsworth, who reviews the evidence as a former pharma-industry analyst — never as your clinician.
Oak at a glance
- Semaglutide
- $119/mo
- Tirzepatide
- $185/mo
- Coverage
- 45+ states (exclusions not published)
- Brand-name
- Compounded only
How we scored Oak
Each factor is scored from Oak's real pricing, disclosures and oversight, then combined into the 71/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
No postpartum, breastfeeding, or hormonal framing — a generic program.
Support is thin once the prescription ships.
Complaints cluster around billing lock-in and hard cancellation.
How we verified this review
- Last verified
- July 2026
- Confidence
- medium
- Primary source
- www.oaklovesyou.com
Homepage 'from' prices ($119 semaglutide / $185 tirzepatide, all doses) verified on oaklovesyou.com; the true single-month rate (reported nearer $235/$285) is anchored behind a longer commitment and surfaces inside the funnel. LegitScript seal shown; compounding pharmacy and medical director not named. Confirm your state and the real per-month price before committing.
What to expect when you sign up
We walked Oak's public signup funnel (July 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage headline prices read 'from $119/$185, one price, all dosages, no subscriptions,' with a $200-off new-patient offer
- 2An unusually thorough async intake screens personal and family thyroid-cancer history (MTC/MEN-2) and requires a full-body photo upload
- 3A doctor reviews the questionnaire — same-day approval, no required video visit
- 4The headline rate is tied to a longer commitment; the real single-month price surfaces inside the funnel
What we noticed
- The 'from' headline is a commitment-anchored rate — a single month runs closer to $235 (semaglutide) / $285 (tirzepatide) per third-party reviews
- The intake genuinely screens thyroid-cancer risk (MTC/MEN-2), which not every competitor does
- The terms are strict: no refunds once medication ships, plus binding arbitration and a class-action waiver
Pricing
Prices re-verified
| Medication | Plan | Monthly |
|---|---|---|
| Compounded semaglutide | All doses (from)Homepage 'from $119/mo, all dosages'; the low rate is anchored to a longer commitment — a single month runs meaningfully higher. Confirm on site. | $119 |
| Compounded tirzepatide | All doses (from)Homepage 'from $185/mo, all dosages'; a single month runs meaningfully higher than the headline. | $185 |
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Oak's public disclosures at last review and change often; confirm the current number on Oak's own site.
What we like
- Flat 'one price, all dosages' structure on both molecules, with an oral option
- An unusually thorough intake that screens thyroid-cancer risk (MTC/MEN-2)
- Async, same-day approval with no required video visit; LegitScript seal shown
- A $200-off new-patient offer on the first bill
The caveats
- The 'from $119/$185' headline is commitment-anchored — a single month runs closer to $235/$285
- No refunds once medication ships, plus binding arbitration and a class-action waiver
- Doesn't name its compounding pharmacy or a medical director; a BC address sits behind a Delaware entity
- Serves ~45 states (exclusions not published) and offers no maternal framing
Oak for mothers: our verdict
A flat, all-dose compounded price with an oral option and a genuinely thorough intake — undercut by a headline that isn't the real month-to-month number and terms that lock you in hard once the box ships. It runs about $119/month, flat across every dose — toward the affordable end of what we track.
We weigh Oak the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Oak actually costs
- Compounded semaglutide — All doses (from): $119/mo
- Compounded tirzepatide — All doses (from): $185/mo
That sits below the roughly $149 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Oak prescribes
Oak prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Oak fits — and where it doesn't — for mothers
A good fit if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Oak is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers drawn to a flat all-dose price and an oral option who will price the true single-month rate — not the headline — and can live with strict, no-refund terms.
Alternatives to Oak
The top-scoring providers our editors recommend for mothers — CoreAge Rx leads our Editors' Rating. Some of these links earn MetabolicMoms a referral fee; it never changes the rating.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Trimi Health
The budget line on this masthead, and an honest one: some of the lowest flat, all-dose compounded pricing we track — provided you read the annual-prepay footnote before the headline number seduces you.
- Visit SynergyRx
The least transparent option we've wired for mothers: it won't show a GLP-1 price until after a consult, a review reports its intake skips the thyroid-cancer screen, and it carries the thinnest track record of the three near-identical CareGLP brands.
Keep comparing Oak
Head-to-head & alternatives
Oak, answered
- Is Oak's 'from $119' the price I'll actually pay?
- Not month to month. The $119 semaglutide and $185 tirzepatide figures are 'one price, all dosages' headline rates anchored to a longer commitment; third-party reviews put the true single-month price nearer $235 and $285. A $200-off new-patient offer softens the first bill. For a mother budgeting honestly, price the single-month rate — not the headline — and confirm the current number inside Oak's funnel before you enroll.
- What should a mother know about Oak's cancellation terms?
- This is the part to read twice. Oak markets 'no subscriptions,' but its terms state that once medication ships, refunds are not issued under any circumstances, and enrollment includes binding arbitration and a class-action waiver. For a mother whose plans can shift — a nursing stretch, a pregnancy, a change in priorities — that's a rigid place to be locked in. Weigh it against a provider with a cancellation path you can actually find.
- Does Oak screen for the risks that matter?
- To its credit, yes — more than some. Oak's async intake screens personal and family history of medullary thyroid cancer and MEN-2 (the GLP-1 black-box contraindication) and requires a full-body photo, which is more diligence than a bare quiz. It carries a LegitScript seal, though it doesn't name its compounding pharmacy or a medical director. As always, no GLP-1 is established as safe in pregnancy or breastfeeding — plan the timing with your clinician.
Pricing, states and verification reflect Oak's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.